Skip to main content
Fig. 3 | Trials

Fig. 3

From: Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial

Fig. 3

Interpretation rules for the assessment of the benefit and harm outcomes: prednisolone versus placebo group. a Interpretation rules for benefit: prednisolone versus placebo group. b Interpretation rules for harm: prednisolone versus placebo group. c Combined assessment for benefit and harm: prednisolone versus placebo group

Back to article page